heart risk | The Robert Scott Bell Show

Government and Media

Abbott Labs Pulls Obesity Drug Over Heart Risk

October 12, 2010 RSB Staff Abbott Labs, big pharma, cardiovascular problems, Center for Drug Evaluation and Research, diet, drugs, exercise, fda, heart disease, heart risk, Meridia, obese, obesity, overweight, patients, pharmaceutical giant, pharmacists, placebo, Sibutramine Cardiovascular Outcomes Trial, Slimming Beauty, stroke, weight loss

The obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and

Health Concerns

Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds

July 22, 2010 RSB Staff Avandia, diabetes drug, Dr. Alan Kadish, Dr. Ellen Strahlman, Dr. Kirk Garratt, fda, GlaxoSmithkline's, Government and Media, heart risk, inerventional cardiovascular research, label revisions, Lenox Hospital, market, medicines, New York Times, Physicians, safety reasons

The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but

Copyright © 2023 The Robert Scott Bell Show. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.